UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038137
Receipt number R000043460
Scientific Title International Risk Assessment of Cnm-positive S. mutans in Stroke and Vascular Dementia Surveillance
Date of disclosure of the study information 2019/09/28
Last modified on 2020/07/23 09:12:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

International Risk Assessment of Cnm-positive S. mutans in Stroke and Vascular Dementia Surveillance

Acronym

International-RAMESSES trial

Scientific Title

International Risk Assessment of Cnm-positive S. mutans in Stroke and Vascular Dementia Surveillance

Scientific Title:Acronym

International-RAMESSES trial

Region

Japan Asia(except Japan) Africa


Condition

Condition

stroke, intracerebral hemorrhage, cerebral microbleeds, lacunar stroke, dementia, Alzheimer's dementia, vascular dementia

Classification by specialty

Neurology Infectious disease Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Recently, we proposed the novel concept, Brain-Oral Axis, focusing on the specific strain of cariogenic bacteria, Streptococcus mutans expressing collagen-binding protein Cnm (Cnm+ S. mutans) as underlying mechanism of spontaneous intracerebral hemorrhage (sICH), hemorrhagic small vessel diseases (SVDs), and vascular dementia in both experimental and cohort studies held in Japan. However, there are few available data of other Asian and African countries, where the global burden of ICH was increased in recent two decades. In this international collaboration study, we aimed to research the relationship between oral microbiota and stroke or dementia.

Basic objectives2

Others

Basic objectives -Others

exploratory research

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Stroke Cohort Study: Prevalence of Cnm+ S. mutans in the oral cavity (saliva and dental plaque) among subjects with stroke (ischemic stroke, or hemorrhagic stroke).
Dementia Cohort Study: Prevalence of Cnm+ S. mutans in the oral cavity (saliva and dental plaque) in dementia (Alzheimer disease, vascular dementia, mixed type).

Key secondary outcomes

The association between prevalence of Cnm+ S. mutans in oral cavity and
1. self-reported dental health and number of naturally remaining teeth in eath ethnicity.
2. the location of ICH (lobar, deep, or mixed) in the stroke cohort study.
3. the estimated hematoma volume of ICH in the stroke cohort study
4. SVD markers on brain MRI (White matter hyperintensity, lacunar infarction, cerebral microbleeds, enlargement of perivascular space) and hippocampus atrophy in the dementia cohort study.
5. the score of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) in the dementia cohort study.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

Stroke Cohort Study
Subjects
1. 85>= age >= 18 years old
2. First Ever Stroke (within 5 years from the onset)
3. Diagnosis based on brain imaging (computed tomography or magnetic resonance imaging)
4. A written informed consent has been obtained from the subjects or relatives

Dementia Cohort Study
Subjects
1. 88>= age >= 55 years old
2. modified Rankin Scale <= 3
3. 0.5<= Clinical Dementia Rating <= 2.0
4. MMSE score <23
5. Evaluation of 3.0 tesla brain MRI imag ing within 5 years
6. A written informed consent has been obtained from the subhects or relatives

Key exclusion criteria

1. case with no natural remaining teeth
2. case who are difficult to communicate due to unconsciousness
3. case judged inappropriate by researchers by any other reason
Stroke Cohort Study
4. case with recurrent stroke
Dementia Cohort Study
4. cases who suffered other systemic diseases that clearly affect cognitive function within 3 months.

Target sample size

700


Research contact person

Name of lead principal investigator

1st name Masafumi
Middle name
Last name Ihara

Organization

National Cerebral and Cardiovascular Center

Division name

Department of Neurology

Zip code

564-8565

Address

6-1, Shimmachi, Kishibe, Suita, Osaka

TEL

06-6170-1070

Email

ihara@ncvc.go.jp


Public contact

Name of contact person

1st name Shuichi
Middle name
Last name Tonomura

Organization

National Cerebral and Cardiovascular Center

Division name

Department of Neurology

Zip code

564-8565

Address

6-1, Shimmachi, Kishibe, Suita, Osaka

TEL

06-6170-1070

Homepage URL


Email

tonomura.shuichi58@ncvc.go.jp


Sponsor or person

Institute

Department of Neurology, National Cerebral and Cardiovascular Center

Institute

Department

Personal name



Funding Source

Organization

Grant-in-Aid for Scientific Research (B)
Grant-in-Aid for Challenging Exploratory Research

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Division of Oral Infection and Disease Control, Osaka University Graduate School of Dentistry, Osaka, Japan.
Department of Human Anatomy, University of Nairobi, Kenya.
Department of Medicine, Federal Medical Centre, Abeokuta, Nigeria.
Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Memory Aging and Cognition Centre, National University Health System, Singapore, Singapore
Department of Neurology, Alkhairaat University, Palu, Central Sulawesi, Indonesia

Name of secondary funder(s)

The OHYAMA health Foundation
The NOVARTIS Foundation for the Promotion of Science, Japan
The Japan Heart Foundation, Japan
The Smoking Research Foundation, Japan
Oyama health foundation, Japan


IRB Contact (For public release)

Organization

National Cerebral and Cardiovascular Center

Address

6-1, Shimmachi, Kishibe, Suita, Osaka

Tel

06-6170-1070

Email

rec-office-ac@ncvc.go.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

jRCT1050190051

Org. issuing International ID_1

National Institute of Public Health, Japan

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立循環器病研究センター(大阪府)、大阪大学大学院歯学研究科(大阪府)、Department of Human Anatomy, University of Nairobi(Nairobi, Kenya)、Department of Medicine, Kenyatta National Hospital (Nairobi, Kenya)、Department of Medicine, Federal Medical Centre (Abeokuta, Nigeria)、Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan (Ibadan, Nigeria)、Memory Aging and Cognition Centre, National University Health System, (Singapore, Singapore)、Hassanuddin University(Makassar, Indonesia)、Philippine General Hospital(Philippine)


Other administrative information

Date of disclosure of the study information

2019 Year 09 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 08 Month 14 Day

Date of IRB

2019 Year 08 Month 28 Day

Anticipated trial start date

2020 Year 07 Month 01 Day

Last follow-up date

2025 Year 04 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2019 Year 09 Month 27 Day

Last modified on

2020 Year 07 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043460